As of June 30, 2026, Asiamedic Limited carries a market capitalization of 26.40M, placing it among publicly traded companies globally. Its enterprise value stands at 36.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 26.40M |
| Enterprise Value | 36.63M |
As of June 30, 2026, Asiamedic Limited has 1.15B shares outstanding.
| Shares Outstanding | 1.15B |
These figures are as of June 30, 2026.
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.63 |
As of June 30, 2026, Asiamedic Limited maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.25 |
| Quick Ratio | 1.12 |
| Debt / Equity | 90.86 |
As of the close on October 22, 2026, Asiamedic Limited's stock has declined approximately 23.81% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| 52-Week Price Change | -23.81% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
As of June 30, 2026, Asiamedic Limited holds 8.45M in cash and equivalents against 16.61M in total debt, resulting in a net debt position of -3.37M. Total book value stands at 16.20M, with working capital of 9.48M providing operational flexibility.
| Cash & Cash Equivalents | 8.45M |
| Total Debt | 16.61M |
| Net Debt | -3.37M |
| Equity (Book Value) | 16.20M |
| Book Value Per Share | 0.01 |
| Working Capital | 9.48M |
Asiamedic Limited's most recent stock split took place on December 16, 2019 with a 61:65 split ratio.
| Last Split Date | 12/16/2019 |
| Split Ratio | 61:65 |
Already premium?